Fred Binka
Director/Board Member at International Vaccine Institute
Profile
Fred Binka is a trustee at Malaria Consortium and International Vaccine Institute.
He has a graduate degree from The Hebrew University of Jerusalem and an undergraduate degree from the University of Basel.
Fred Binka active positions
| Companies | Position | Start |
|---|---|---|
International Vaccine Institute
 International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015. | Director/Board Member | 2013-11-17 |
Malaria Consortium
 Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson. | Director/Board Member | - |
Training of Fred Binka
| University of Basel | Undergraduate Degree |
| The Hebrew University of Jerusalem | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
International Vaccine Institute
International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015. | Commercial Services |
Malaria Consortium
Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson. | Health Services |
- Stock Market
- Insiders
- Fred Binka
